-
Product Insights
NewLikelihood of Approval Analysis for Female Infertility
Overview How likely is it that the drugs in Female Infertility will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Female Infertility Overview Female infertility refers to infertility in women. Causes or...
-
Sector Analysis
NewStone Management Disposables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Stone Management Disposables Market Overview The stone management disposables market size was valued at $733.4 million in 2023. Factors such as increasing population and changing lifestyles will drive the market growth at a CAGR of more than 5% from 2023 to 2033. Nephrolithiasis is the process of formation of kidney stones in the kidney or at the lower end of the urinary tract. Urinary tract stones are known to occur more commonly in men than in women. The occurrence ratio...
-
Company Insights
Business of Women’s Super League (WSL) 2023-24 – Property Profile, Sponsorship and Media Landscape
Women’s Super League (WSL) 2023-2024 Report Overview Women’s Super League (WSL) 2023-2024 sponsorship revenue is estimated to be $65 million. Barclays Women’s Super League has 31 broadcast deals out of which 29 are international, airing the WSL around the globe. The Women’s Super League (WSL) 2023-2024 report provides an analysis of the Women’s Super League 2023-2024, including a look at the league sponsorship, attendance and tickets, media landscape, kit sponsorship, and club sponsorship analysis. It includes a detailed overview of...
-
Sector Analysis
NewMethicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
Methicillin-Resistant Staphylococcus aureus (MRSA) Report Overview In the 7MM, there were 714,131 hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) in 2023. The hospitalized incident cases of Methicillin-Resistant Staphylococcus aureus (MRSA) will register an AGR of more than 1% during 2023-2033. Methicillin-resistant Staphylococcus aureus (MRSA) is a virulent, antibiotic-resistant bacteria that is associated with considerable morbidity and mortality. MRSA can be categorized according to the setting in which the infection was acquired, as either healthcare-associated MRSA (HA-MRSA), which is acquired...
-
Product Insights
NewLikelihood of Approval Analysis for Malaria
Overview How likely is it that the drugs in Malaria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malaria Overview Malaria is a life-threatening blood disease caused by a parasite (Plasmodium)...
-
Product Insights
NewLikelihood of Approval Analysis for Post Menopausal Osteoporosis
Overview How likely is it that the drugs in Post Menopausal Osteoporosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Post Menopausal Osteoporosis Overview Postmenopausal osteoporosis is the most common form...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Metastatic Breast Cancer Drug Details: Palbociclib (Ibrance, Agatha)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Chordoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Chordoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Chordoma Drug Details: Palbociclib (Ibrance, Agatha) is a pyridopyrimidine-derived cyclin-dependent...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Nonmelanomatous Skin Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Nonmelanomatous Skin Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Nonmelanomatous Skin Cancer Drug Details: Palbociclib (Ibrance, Agatha) is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Palbociclib in Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Palbociclib in Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Palbociclib in Liposarcoma Drug Details: Palbociclib (Ibrance, Agatha) is a pyridopyrimidine-derived cyclin-dependent kinase...